Stay updated on Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer displays revision v3.7.2 instead of v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T22:31:46.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site's footer revision changed from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:21:37.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page instead of the study content. The error page includes the site chrome (header/footer) and blocks access to the study record.
    Difference
    13%
    Check dated 2026-09-19T21:59:10.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, replacing the previous v3.6.5, indicating an internal site update. There is no evident change to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-29T21:48:08.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The revision label on the page was updated to v3.6.5, replacing the previous v3.6.4, signaling a new build of the site.
    Difference
    0.1%
    Check dated 2026-08-08T19:48:46.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.3 to v3.6.4, signaling a new build of the site. No study-related content changes are indicated.
    Difference
    0.1%
    Check dated 2026-07-25T11:49:12.000Z thumbnail image

Stay in the know with updates to Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.